T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Zoom
ZM
|
$2.88B |
| 2 |
Eli Lilly
LLY
|
$2.63B |
| 3 |
AstraZeneca
AZN
|
$1.96B |
| 4 |
Fortinet
FTNT
|
$1.66B |
| 5 |
Coupang
CPNG
|
$1.63B |
Top Sells
| 1 |
NXP Semiconductors
NXPI
|
$2.58B |
| 2 |
Morgan Stanley
MS
|
$2.29B |
| 3 |
Airbnb
ABNB
|
$2.07B |
| 4 |
NVIDIA
NVDA
|
$1.8B |
| 5 |
Qualcomm
QCOM
|
$1.79B |
Sector Composition
| 1 | Technology | 23.37% |
| 2 | Healthcare | 16.2% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Acadia Healthcare
ACHC
$2.12B
| $616M | 0.06% |
10,782,501
+450,307
| +4% | +$25.7M |
|
302
AvalonBay Communities
AVB
$27.5B
| $606M | 0.06% |
3,282,494
-40,527
| -1% | -$7.48M |
|
303
EQT Corp
EQT
$31.8B
| $599M | 0.06% |
32,217,017
+435,133
| +1% | +$8.08M |
|
304
Cardinal Health
CAH
$35.8B
| $586M | 0.06% |
9,646,259
+640,591
| +7% | +$38.9M |
|
305
Lowe's Companies
LOW
$153B
| $585M | 0.06% |
3,075,093
+973,815
| +46% | +$185M |
|
306
Crown Castle
CCI
$40.2B
| $583M | 0.06% |
3,387,835
-324,423
| -9% | -$55.8M |
|
307
Freeport-McMoran
FCX
$66.6B
| $576M | 0.06% |
17,487,028
-17,491,635
| -50% | -$576M |
|
308
Ionis Pharmaceuticals
IONS
$9.69B
| $566M | 0.06% |
12,580,056
-534,911
| -4% | -$24M |
|
309
Array Technologies
ARRY
$1.32B
| $565M | 0.06% |
18,946,859
+1,458,059
| +8% | +$43.5M |
|
310
Neurocrine Biosciences
NBIX
$14.3B
| $561M | 0.06% |
5,773,359
-498,371
| -8% | -$48.5M |
|
311
GSK
GSK
$80.5B
| $555M | 0.06% |
12,434,625
-807,069
| -6% | -$36M |
|
312
Willis Towers Watson
WTW
$32.3B
| $543M | 0.05% |
2,370,331
-1,180,345
| -33% | -$270M |
|
|
PRAH
313
DELISTED
PRA Health Sciences, Inc.
PRAH
| $542M | 0.05% |
3,533,621
-3,521,239
| -50% | -$540M |
|
314
SiteOne Landscape Supply
SITE
$6.79B
| $542M | 0.05% |
3,172,066
-114,585
| -3% | -$19.6M |
|
315
FirstEnergy
FE
$24.9B
| $540M | 0.05% |
15,559,701
+816,264
| +6% | +$28.3M |
|
316
VeriSign
VRSN
$26.3B
| $539M | 0.05% |
2,711,586
+688,880
| +34% | +$137M |
|
317
Raymond James Financial
RJF
$33B
| $539M | 0.05% |
6,594,069
-939,264
| -12% | -$76.7M |
|
|
PPD
318
DELISTED
PPD, Inc. Common Stock
PPD
| $534M | 0.05% |
14,100,789
+1,068,055
| +8% | +$40.4M |
|
319
Armstrong World Industries
AWI
$8.56B
| $533M | 0.05% |
5,920,413
-913,626
| -13% | -$82.3M |
|
320
Treehouse Foods
THS
$891M
| $533M | 0.05% |
10,198,228
+58,895
| +0.6% | +$3.08M |
|
321
Alaska Air
ALK
$7.37B
| $532M | 0.05% |
7,682,219
-1,481,271
| -16% | -$103M |
|
322
MongoDB
MDB
$26.4B
| $530M | 0.05% |
1,980,429
-125,058
| -6% | -$33.4M |
|
323
ICU Medical
ICUI
$3.22B
| $530M | 0.05% |
2,577,820
-62,544
| -2% | -$12.8M |
|
324
AXIS Capital
AXS
$7.65B
| $526M | 0.05% |
10,609,389
-73,166
| -0.7% | -$3.63M |
|
325
Imperial Oil
IMO
$44.4B
| $525M | 0.05% |
21,732,102
-2,362,180
| -10% | -$57.1M |
|